Back to Search Start Over

NT-proBNP Mediates the Association Between FGF23 and All-Cause Mortality in Individuals With Type 2 Diabetes.

Authors :
van der Vaart A
Bakker SJL
Laverman GD
van Dijk PR
de Borst MH
Source :
Journal of the American Heart Association [J Am Heart Assoc] 2023 Dec 05; Vol. 12 (23), pp. e031873. Date of Electronic Publication: 2023 Nov 28.
Publication Year :
2023

Abstract

Background: FGF23 (fibroblast growth factor 23) is associated with a higher mortality risk in type 2 diabetes, but the mechanism is unclear. We aimed to study whether NT-proBNP (N-terminal pro-brain natriuretic peptide) mediates the association between FGF23 and mortality.<br />Methods and Results: We analyzed C-terminal FGF23 and NT-proBNP levels in 399 patients with type 2 diabetes. Cox regression analyses were performed, followed by mediation analyses using Structural Equation Modeling. During follow-up of 9.2 [7.6-11.3] years, 117 individuals died. FGF23 was associated with all-cause mortality, independent of potential confounders (fully adjusted hazard ratio [HR], 2.32 [95% CI, 1.21-4.43], P =0.01). The association was lost upon further adjustment for NT-proBNP (HR, 1.84; 95% CI, 0.91-3.73). NT-proBNP accounted for 26% of the mediation effect between FGF23 and all-cause mortality.<br />Conclusions: These findings suggest that a higher FGF23 level is associated with increased mortality in individuals with type 2 diabetes through an effect on volume homeostasis.

Details

Language :
English
ISSN :
2047-9980
Volume :
12
Issue :
23
Database :
MEDLINE
Journal :
Journal of the American Heart Association
Publication Type :
Academic Journal
Accession number :
38014662
Full Text :
https://doi.org/10.1161/JAHA.123.031873